The Asn-292→Ser and Ser-477→Stop mutations of the lipoprotein lipase gene and their significance for lipid metabolism in patients with hypertriglyceridaemia

European Journal of Clinical Investigation

Volumn 27, Issue 11, 1997, Pages 928-935

  Knudsen, P ^a   Murtomaki S ^b   Antikainen, M ^b,c   Ehnholm, S ^b   Lahdenpera S ^a   Ehnholm, C ^b   Taskinen, M R ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Hepatic lipase; Hypertriglyceridaemia; Lipoprotein lipase; Mutation; Population

Indexed keywords

LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; VERY LOW DENSITY LIPOPROTEIN; LIPOPROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; HYPERTRIGLYCERIDEMIA; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; AGED; BLOOD; GENETICS; METABOLISM; MIDDLE AGED; MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; LIPID METABOLISM; LIPOPROTEIN LIPASE; LIPOPROTEINS; MALE; MIDDLE AGED; MUTATION;

EID: 0030613024     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.2190767.x     Document Type: Article

References (51)

1. Brunzell JD. Familiar lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In: Scriver C, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease. New York: McGraw-Hill 1989:1165-80.
2. Breckenridge WC, Little JA, Steiner G, Chow A, Poapst M. Hypertriglyceridemia associated with deficiency of apolipoprotein C-II N Engl J Med 1978;298:1265-73.
3. Brunzell JD, Miller NE, Alaupovic P et al. Familial chylomicronemia due to a circulating inhibitor of lipoprotein lipase activity. J Lipid Res 1983;24:12-19.
4. McIntyre N, Harry DS. Lipids and lipoproteins in clinical practice. London: Wolfe Publishing 1992.
5. Taskinen M-R. Insulin resistance and lipoprotein metabolism. Curr Opin Lipidol 1995;6:153-60.
6. Austin MA, Hokanson JE. Epidemiology of triglycerides, small dense low-density lipoprotein, and lipoprotein Lp (a) as risk factors for coronary heart disease. Medic Clin North Am 1994;78:99-115.
7. Benlian P, De Gennes JL, Foubert L et al. Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. N Engl J Med 1996;335:848-54.
8. Miller GJ, Miller NE. Plasma high-density lipoprotein concentration and the development of ischemic heart disease. Lancet 1975;1:16-19.
9. Ebenbichler CF, Kirchmair R, Egger JR, Patsch JR. Postprandial state and atherosclerosis. Curr Opin Lipidol 1995;6:286-90.
10. Laakso M. Lipids and lipoproteins as risk factors for coronary heart disease in non-insulin-dependent diabetes mellitus. Ann Med 1996;28:341-5.
11. Austin MA. Plasma triglyceride as a risk factor for coronary heart disease. Am J Epidemiol 1989;129:249-59.
12. Davignon J, Cohn JS. Triglycerides: a risk factor for coronary heart disease. Atherosclerosis 1996;124 (Suppl.): S57-S64.
13. Deeb SS, Peng R. Structure of the human lipoprotein lipase gene. Biochemistry 1989;28:4131-5.
14. Lalouel J-M, Wilson DE, Iverius P-H. Lipoprotein lipase and hepatic triglyceride lipase: molecular and genetic aspects. Curr Opin Lipidol 1992;3:86-95.
15. Antikainen M, Tenkanen H, Taskinen M-R, Ehnholm C. Genetic variations affecting human lipoprotein lipase gene. German J Gastroenterol 1996; Suppl. 3:59-61.
16. Reymer PWA, Gagné E, Groenemeyer BE et al. A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL-cholesterol levels in premature atherosclerosis. Nature Genetics 1995;10:28-34.
17. Jemaa R, Fumeron F, Poirier O et al. Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. J Lipid Res 1995;36:2141-6.
18. Fisher RM, Mailly F, Peacock RE et al. Interaction of the lipoprotein lipase Asn291→Ser mutation with body mass index determines elevated plasma triacylglycerol concentrations: A study in hyperlipidemic subjects, myocardial infarctation survivors and healthy adults. J Lipid Res 1995;36:2104-12.
19. Funke H, Assman G. The low down on lipoprotein lipase. Nature Genetics 1995;10:6-7.
20. Wilson DE, Emi M, Iverius P-H et al. Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation. J Clin Invest 1990;86:735-50.
21. Wilson DE, Hata A, Kwong LK et al. Mutations in exon 3 of the lipoprotein lipase gene segregating in a family with hypertriglyceridemia, pancreatis and non-insulin-dependent diabetes. J Clin Invest 1993;92:203-11.
22. Ma Y, Ooi TC, Liu M-S et al. High frequency of mutations in the human lipoprotein lipase gene in pregnancy-induced chylomicronemia: a possible association with apolipoprotein E2 isoform. J Lipid Res 1994;35:1066-75.
23. Reymer PWA, Groenemeyer BE, Gagné E et al. A frequently occuring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia. Hum Mol Gen 1995;4:1543-49.
24. Zhang H, Reymer PWA, Liu M-S et al. Patients with ApoE3 deficiency (E2/2, E3/2 and E4/2) who manifest with hypertriglyceridemia have increased frequency of an Asn291→Ser mutation in the human LPL gene. Arterioscler Thromb Vasc Biol 1995;15:1695-703.
25. Pimstone SN, Gagné SE, Gagné C et al. Mutations in the gene for lipoprotein lipase: A cause for low HDL-cholesterol levels in individuals heterozygous for familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 1995;15:1704-12.
26. Miesenböck G, Hölzl B, Föger B et al. Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities. J Clin Invest 1993;91:448-55.
27. Nykjær A, Nielsen M, Lookene A et al. A Carboxyl-terminal fragment of lipoprotein lipase binds to the low-density lipoprotein receptor- related protein and inhibits lipase-mediated uptake of lipoproteins in cells. J Biol Chem 1994;269:31747-55.
28. Goldberg IJ. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 1996;37:693-707.
29. Ehnholm C, Kuusi T. Preparation, characterization and measurement of hepatic lipase. Methods Enzymol 1986;129:716-38.
30. Syvänen AC, Aalto-Setälä K, Harju L, Kontula K, Söderlund H. A primer-guided nucleotide incorporation assay in the genotyping of apolipoprotein E. Genomics 1990;8:684-92.
31. Bengström M, Jungell-Nortamo A, Syvänen A-C. Biotinylation of oligonucleotides using a water-soluble biotin ester. Nucleosides Nucleotides 1990;9:123-7.
32. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345-53.
33. Röschlau P, Bernt E, Gruber E. Enzymatische Bestimmung des Gesamt-Cholesterins im Serum. Z Klin Chem Klin Biochem 1974;12:403-7.
34. Wahlefeld AW. Triglycerides. Determination after enzymatic hydrolysis. In: Bergmeyer HU ed. Methods of enzymatic analysis, 2nd edn. New York: Verlag-Chemie, Weinheim; Academic Press 1974: 1831-5.
35. Kashyap MR, Hynd BA, Robinson K. A rapid and simple method for measurement of total protein in very low-density lipoproteins by the Lowry assay. J Lipid Res 1980;21:491-5.
36. Ehnholm C, Lukka M, Kuusi T, Nikkilä EA, Utermann G. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res 1986;27:227-35.
37. 291→Ser human lipoprotein lipase is associated with reduced catalytic activity and does not influence binding to heparin. FEBS Lett 1995;367:257-62.
38. Syvänne M, Antikainen M, Ehnholm S et al. Heterozygosity for Asn291Ser mutation in the lipoprotein lipase gene in two Finnish pedigrees: effect of hyperinsulinemia on the expression of hypertriglyceridemia. J Lipid Res 1996;37:727-38.
39. DeBruin TWA, Mailly F, van Barlingen HJJ et al. Lipoprotein lipase gene mutations D9N and N291S in four pedigrees with familial combined hyperlipidaemia. Eur J Clin Invest 1996;26:631-39.
40. Minnich A, Kessling A, Roy M et al. Prevalence of alleles encoding defective lipoprotein lipase in hypertriglyceridemic patients of French Canadian descent. J Lipid Res 1995;36:117-24.
41. Taskinen M-R. Lipoprotein lipase in hypertriglyceridemias. In: Borensztajn J, ed. Lipoprotein lipase. Chigaco: Evener Publishers. 1987:201-28.
42. Blades B, Vega GL, Grundy SM. Activities of lipoprotein lipase and hepatic triglyceride lipase in post-heparin plasma of patients with low concentrations of high-density lipoprotein cholesterol. Arterioscler Thromb 1993;13:1227-35.
43. Elbein SC, Yeager C, Kwong LK et al. Molecular screening of the lipoprotein lipase gene in hypertriglyceridemic members of familial noninsulin-dependent diabetes mellitus families. J Clin Endocrinol Metab 1994;79:1450-6.
44. Kozaki K, Gotoda T, Kawamura M et al. Mutational analysis of human lipoprotein lipase by carboxy-terminal truncation. J Lipid Res 1993;34:1765-72.
45. 410→Val) leads to enzyme inactivation and familial chylomicronemia. J Lipid Res 1994;35:1552-60.
46. 156→Gly) causing familial lipoprotein lipase deficiency. J Biol Chem 1991;266:14418-24.
47. 447→a stop codon) in lipoprotein lipase contributes to a defect in lipid interface recognition in a case with type I hyperlipidemia. Biochem Biophys Res Communication 1992;182:70-7.
48. Stocks J, Thorn JA, Galton DJ. Lipoprotein lipase genotypes for a common termination codon mutation detected by PCR-mediated site-directed mutagenesis and restriction digestion. J Lipid Res 1992;33:853-7.
49. Gagné E, Genest J, Zhang H, Clarke LA, Hayden MR. Analysis of DNA changes in the LPL gene in patients with familial combined hyperlipidemia. Arterioscler Thromb 1994;14:1250-7.
50. Mattu RK, Needham EWA, Morgan R et al DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population. Arterioscler Thromb 1994;14:1090-7.
51. Nevin DN, Brunzell JD, Deeb SS. The LPL gene in individuals with familial combined hyperlipidemia and decreased LPL activity. Arterioscler Thromb 1994;14:869-73.